| Symbol |
Name |
|
AJUBA
|
ajuba LIM protein
|
|
AMOT
|
angiomotin
|
|
BUB1B-PAK6
|
BUB1B-PAK6 readthrough
|
|
CCN2
|
cellular communication network factor 2
|
|
CCND1
|
cyclin D1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH10
|
cadherin 10, type 2 (T2-cadherin)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH12
|
cadherin 12, type 2 (N-cadherin 2)
|
|
CDH13
|
cadherin 13
|
|
CDH15
|
cadherin 15, type 1, M-cadherin (myotubule)
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH18
|
cadherin 18, type 2
|
|
CDH19
|
cadherin 19, type 2
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH20
|
cadherin 20, type 2
|
|
CDH22
|
cadherin 22, type 2
|
|
CDH24
|
cadherin 24, type 2
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney)
|
|
CDH7
|
cadherin 7, type 2
|
|
CDH8
|
cadherin 8, type 2
|
|
CDH9
|
cadherin 9, type 2 (T1-cadherin)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL4A
|
cullin 4A
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
DCAF1
|
DDB1 and CUL4 associated factor 1
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHA2
|
EPH receptor A2
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXM1
|
forkhead box M1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
INSR
|
insulin receptor
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA10
|
integrin, alpha 10
|
|
ITGA11
|
integrin, alpha 11
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGA8
|
integrin, alpha 8
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAD
|
integrin, alpha D
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB6
|
integrin, beta 6
|
|
ITGB7
|
integrin, beta 7
|
|
ITGB8
|
integrin, beta 8
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MST1
|
macrophage stimulating 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NGFR
|
nerve growth factor receptor
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAK5
|
p21 (RAC1) activated kinase 5
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta
|
|
PRKAR2A
|
protein kinase, cAMP-dependent, regulatory, type II, alpha
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
STK3
|
serine/threonine kinase 3
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TEAD2
|
TEA domain family member 2
|
|
TEAD3
|
TEA domain family member 3
|
|
TEAD4
|
TEA domain family member 4
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
VGLL4
|
vestigial-like family member 4
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
YAP1
|
Yes-associated protein 1
|
